Genetic susceptibility influences the association between cell phone use and thyroid cancer

Genetic susceptibility influences the association between cell phone use and thyroid cancer

New therapeutic strategy for lung cancer and associated secondary tumors The findings suggest that genetic susceptibilities play an important role in cell phone use and the risk of developing thyroid cancer and could help to identify subgroups who are potentially at risk. Further research is needed to confirm the findings and to better understand the interaction between cell phone radiation and SNPs within specific genes. The rates of thyroid cancer have been steadily increasing in the United States and in many other parts of the world, Zhang said. According to the American Cancer Society's most recent report, there were nearly 53,000 new cases of thyroid cancer in the United States, resulting in 2,180 deaths. Thyroid cancer is three times more common in women and is diagnosed at a younger age than most other cancers. Zhang noted that the study relied on data collected from 2010 to 2011 when smartphones were first being introduced to the market. At the time, only a small proportion of people had smart phones. Therefore, if cell phone use increased the risk of thyroid cancer, it was possibly due to the use of earlier generation cell phones that were more commonly used when the data was collected. Additionally, the transition to smartphones has also seen a major change in how cell phones are used (e.g., texting vs. phone calls). As a result, findings from this current study warrant a further evaluation in future studies, she said. Source: Yale School of Public Health Journal reference: Luo, J., et al. (2020) Genetic susceptibility may modify the association between cell phone use and thyroid cancer: A population-based case-control study in Connecticut. Environmental Research . doi.org/10.1016/j.envres.2019.109013 .



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More